Wave Life Sciences (WVE) Cash & Equivalents Growth (1y) (2015 - 2026)
Powered by 
Analysis
Wave Life Sciences (WVE) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 23.56% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 23.05% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 71.81% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 34.71% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 84.98% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.39% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 28.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -57.58% |
| 10 | Wave Life Sciences | 994.54 Mn | 626.53 Mn | - | 76.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.50% |
| Mar 31, 2026 | 124.02% |
| Dec 31, 2025 | 99.31% |
| Sep 30, 2025 | -36.90% |
| Jun 30, 2025 | 35.39% |
| Mar 31, 2025 | 34.37% |
| Dec 31, 2024 | 50.77% |
| Sep 30, 2024 | 122.20% |
| Jun 30, 2024 | -10.98% |
| Mar 31, 2024 | -12.85% |
| Dec 31, 2023 | 126.39% |
| Sep 30, 2023 | 14.71% |
| Jun 30, 2023 | 16.73% |
| Mar 31, 2023 | 85.85% |
| Dec 31, 2022 | -41.22% |
| Sep 30, 2022 | -1.53% |
| Jun 30, 2022 | 3.03% |
| Mar 31, 2022 | -24.80% |
| Dec 31, 2021 | -18.39% |
| Sep 30, 2021 | -42.74% |